miRNA and Epigenetic Regulations of the Immune Response - Decemeber 11-12, 2008
miRNA and Epigenetic Regulations of the Immune Response - Decemeber 11-12, 2008 miRNA and Epigenetic Regulations of the Immune Response - Decemeber 11-12, 2008
Home Registration Logistics Agenda abstracts  
miRNA and Epigenetic Regulations of the Immune Response - Decemeber 11-12, 2008 miRNA and Epigenetic Regulations of the Immune Response - Decemeber 11-12, 2008

Agenda

Print Version (PDF)
Thursday, December 11, 2008
7:00 – 8:00 a.m. Registration and Continental Breakfast
8:00 – 8:05 a.m. Welcome
Olivier Blondel, NIDDK
8:05 – 8:55 a.m. Keynote Address:  Transcriptional Control of T-cell Activation and Tolerance
Anjana Rao, Harvard Medical School
   
Session 1:  miRNAs and the Immune Response
Chair:  Klaus Rajewsky
8:55 – 9:00 a.m. Introduction
Klaus Rajewsky, Harvard Medical School
9:00 – 9:30 a.m. Gene Regulation by Transcription Factors and microRNAs
Klaus Rajewsky, Harvard Medical School
9:30 – 10:00 a.m. MicroRNA-mediated Regulation of T-cell Development Function
Chang-Zheng Chen, Stanford University School of Medicine
10:00 – 10:30 a.m. Break
10:30 – 11:00 a.m. MicroRNAs in Normal B Cell Development and Lymphomagenesis
Riccardo Dalla-Favera, Columbia University
11:00 – 11:30 a.m. Role of microRNAs in the Innate Immune Response
Mark Lindsay, University of Manchester, United Kingdom
11:30 a.m. – 12:00 p.m. Chromatin Control of Antiviral Response
Alexander Tarakhovsky, The Rockefeller University
12:00 – 1:20 p.m. Lunch
   
Session 2:  Epigenetic Regulation of the Immune Response
Chair:  Matthias Merkenschlager
1:20 – 1:30 p.m. Introduction
Matthias Merkenschlager, Imperial College London, United Kingdom
1:30 – 2:00 p.m. Cohesins in Gene Regulation and Genome Organization
Matthias Merkenschlager, Imperial College London, United Kingdom
2:00 – 2:30 p.m. Chromatin Poises miRNA and Protein-coding Genes for Expression
Keji Zhao, National Heart, Lung, and Blood Institute
2:30 – 3:00 p.m. DNA Methylation Controls FOXP3 Gene Expression
Jochen Huehn, Helmholtz Centre for Infection Research, Germany
3:00 – 3:30 p.m. Break
3:30 – 4:00 p.m. Distal Regulatory Elements and Epigenetic Regulation of Cytokine Expression in T Helper Cells
Christopher Wilson, University of Washington School of Medicine
4:00 – 4:30 p.m. Writers, Readers, and Erasers:  Epigenetic Regulation of the Dendritic Cell and Macrophage Phenotype
Steven Kunkel, University of Michigan Medical School
4:30 – 5:00 p.m. Epigenetic Regulation of Hematopoietic Stem Cell Differentiation
Michele Goodhardt, Institut Universitaire d'Hematologie, Paris
   
Friday, December 12, 2008
7:00 – 8:00 a.m. Registration and Continental Breakfast
8:00 – 8:50 a.m. Keynote Address:  Cytoplasmic Determinants of T-cell Fate
Steven Reiner, University of Pennsylvania
Session 3:  miRNA and Epigenetic Regulations in Autoimmune Diseases
Chair:  Diane Mathis
8:50 – 9:00 a.m. Introduction
Diane Mathis, Joslin Diabetes Center
9:00 – 9:30 a.m. Genetic and Non-genetic Variability in Aire-mediated Control of Immunological Tolerance
Diane Mathis, Joslin Diabetes Center
9:30 – 10:00 a.m. Epigenetics of Autoimmunity
Bruce Richardson, University of Michigan
10:00 – 10:30 a.m. MicroRNAs as Targets of FoxP3 and Regulators of Treg Development and Function
Alexander Rudensky, University of Washington, Seattle
10:30 – 11:00 a.m. Break
11:00 – 11:30 a.m. Genome-wide DNA Methylation Analysis in Monozygotic Twins Discordant for Type-1 Diabetes
Vardhman Rakyan, Institute of Cell and Molecular Science, London
11:30 a.m. – 12:00 p.m. Chemical Biology of Foxp3+ Regulatory T cells (Tregs)
Wayne Hancock, Children’s Hospital of Philadelphia and University of Pennsylvania
12:00 – 12:30 p.m. Regulation of Thymocyte Differentiation by HDAC7
Eric Verdin, University of California at San Francisco
12:30 – 1:40 p.m. Lunch
   
Session 4:  Emerging Therapeutic Strategies in Autoimmune Diseases
Chair:  Judy Lieberman
1:40 – 1:45 p.m. Introduction
Judy Lieberman, Immune Disease Institute, Harvard Medical School
1:45 – 2:15 p.m. Antibody Fragment-mediated Delivery of siRNA Complexes in Specific Immune Compartments
Judy Lieberman, Immune Disease Institute, Harvard Medical School
2:15 – 2:45 p.m. Immune Targeting Nanoparticles Containing siRNAs to Curtail Inflammatory Bowel Diseases
Dan Peer, Tel Aviv University, Israel
2:45 – 3:15 p.m. Oligonucleotide-targeted Dendritic Cells in Autoimmunity
Nick Giannoukakis, Diabetes Institute, University of Pittsburgh
3:15 – 3:30 p.m. Break
3:30 – 4:00 p.m. Folate-mediated Targeting of Drugs and siRNAs to Activated Macrophages In Vivo
Philip Low, Purdue University
4:00 – 4:30 p.m. Amphoteric Liposomes for Targeted Delivery of RNAi in Inflammatory Diseases
Steffen Panzner, novosom AG, Halle, Germany
4:30 p.m. Wrap-up and Adjournment
   

NIH DHHS NIDDK NIAID NIAMS JDRF

Some documents are in various format.
* Documents in PDF format require the free Adobe Acrobat Reader exit-disclaimer Icon application for viewing.
* Documents in DOC format require the free MS Word Viewer. exit-disclaimer Icon for excel and powerpoint
* Documents in XLS format require the free Excel Viewer. exit-disclaimer Icon
* Documents in PPT format require the free PowerPoint Viewer. exit-disclaimer Icon

Contact NIDDK |   Privacy Statement |   Disclaimers |  Freedom of Information Act |  For Staff Only |  Accessibility |  Copyright Status |  Archives Site Map                            

Director: Griffin P. Rodgers, M.D., M.A.C.P
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services.
 
General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
Phone: 301.496.3583